Jim Simons Black Diamond Therapeutics, Inc. Transaction History
Renaissance Technologies LLC
- $56.7 Billion
- Q2 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 263,900 shares of BDTX stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
263,900
Previous 212,600
24.13%
Holding current value
$1.12 Million
Previous $1.08 Million
14.01%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding BDTX
# of Institutions
100Shares Held
47.3MCall Options Held
108KPut Options Held
24.8K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.7MShares$45.1 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.52MShares$36 Million0.66% of portfolio
-
Nea Management Company, LLC Timonium, MD4.45MShares$18.8 Million1.96% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$13.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.13MShares$9.02 Million0.0% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $154M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...